Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC2972 Kt-182

Potent and selective inhibitor of ABHD6

1402612-62-7
DCC2973 Kt2-962

TXA2/prostaglandin endoperoxide receptor antagonist

129648-96-0
DCC2974 Kta-439

Thyroid hormone receptor β (TRβ) selective agonist

575503-70-7
DCC2975 Ku-2285

Hypoxic cell radiosensitizer

121077-11-0
DCC2976 Kufal194

Novel selective DYRK1A inhibitor

DCC2977 Kunb31

Novel potent and selective inhibitor of Hsp90β

2220263-80-7
DCC2978 Kurasoin B

Novel protein farnesyltransferase inhibitor

193696-42-3
DCC2979 kv1.5-in-iiii

Potent Kv1.5 inhibitor

1469902-72-4
DCC2980 Kv2.1/syntaxin-in-cpd5

Novel neuroprotectant, inhibiting Kv2.1-syntaxin molecular interaction

DCC2981 Kva-d-88

Novel Preferable Phosphodiesterase 4B (PDE4B) Inhibitor, Decreasing Cocaine-Mediated Reward Properties in Vivo

2410550-31-9
DCC2982 Ky1022

Ras destabilizer, targeting the Wnt/ß-catenin pathway and inhibiting development of metastatic colorectal cancer

1029721-36-5
DCC2983 Kya1797

Novel inhibitor of the Wnt/ß-catenin pathway, binding directly to the regulators of G-protein signaling domain of axin, initiating ß-catenin and Ras degradation through enhancement of the ß-catenin destruction complex activating GSK3ß, effectively suppres

851304-36-4
DCC2984 Kys05047

Selective T-type Ca(2+) channel blocker with anti-proliferative effects against various cancer cells

839672-57-0
DCC2985 L-161240

Potent inhibitor of LpxC and lipid A biosynthesis

183298-68-2
DCC2986 L-162782

Nonpeptide agonist of angiotensin AT1 receptor

169281-92-9
DCC2987 L17er4

Novel cell-permeable attenuated cationic amphiphilic lytic (ACAL) peptide, efficiently bring immunoglobulin G (IgG) and other functional proteins into cells

DCC2988 L2-4048

Novel Migration Inhibitory Factor (MIF) inhibitor, binding at the allosteric and tautomerase sites, blocking MIF's tautomerase CD74 receptor binding, and pro-inflammatory activities

DCC2989 L458-bpyne

Novel γ-secretase modulator photoaffinity probe, identifying distinct allosteric binding sites on presenilin that can be exploited to reduce levels of pathogenic Aβ species

1374647-07-0
DCC2990 L465046 (α-synuclein Amyloid Aggregation Inhibitor)

Novel inhibitor of α-synuclein amyloid aggregation for the treatment of Parkinson's disease

675171-18-3
DCC2991 L524-0366

Novel inhibitor of the TWEAK-Fn14 signaling cascade

951612-19-4
DCC2992 L61h46

Novel potent inhibitor of human pancreatic cancer cells

DCC2993 L-651392

Potent leukotriene inhibitor

93211-49-5
Page 1357 / Total 1557 FirstPrevNextLastGoto